Department of Microbiology and Immunology
Barbara A. Fox has not added Biography.
If you are Barbara A. Fox and would like to personalize this page please email our Author Liaison for assistance.
De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii.
Nature Feb, 2002 | Pubmed ID: 11859373
Plasmodium falciparum: fine-mapping of an epitope of the serine repeat antigen that is a target of parasite-inhibitory antibodies.
Experimental parasitology May, 2002 | Pubmed ID: 12243740
Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment.
Parasitology international Dec, 2002 | Pubmed ID: 12421632
Organisation and sequence determination of glutamine-dependent carbamoyl phosphate synthetase II in Toxoplasma gondii.
International journal for parasitology Jan, 2003 | Pubmed ID: 12547350
Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation.
International journal for parasitology Mar, 2004 | Pubmed ID: 15003493
Toxoplasma gondii: generation of novel truncation mutations in the linker domain of dihydrofolate reductase-thymidylate synthase.
Experimental parasitology Mar-Apr, 2004 | Pubmed ID: 15172226
Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation.
Journal of immunology (Baltimore, Md. : 1950) Jun, 2006 | Pubmed ID: 16751369
TLR adaptor MyD88 is essential for pathogen control during oral toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2008 | Pubmed ID: 18714019
Genetic identification of essential indels and domains in carbamoyl phosphate synthetase II of Toxoplasma gondii.
International journal for parasitology Apr, 2009 | Pubmed ID: 18992249
Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.
Journal of immunology (Baltimore, Md. : 1950) Jan, 2009 | Pubmed ID: 19124750
Efficient gene replacements in Toxoplasma gondii strains deficient for nonhomologous end joining.
Eukaryotic cell Apr, 2009 | Pubmed ID: 19218423
Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii.
Infection and immunity Sep, 2009 | Pubmed ID: 19528214
Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated type I vaccine strain.
Infection and immunity Dec, 2009 | Pubmed ID: 19797073
CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1.
Infection and immunity Aug, 2010 | Pubmed ID: 20498261
Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii.
Infection and immunity Sep, 2010 | Pubmed ID: 20605980
Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence.
Cell host & microbe Dec, 2010 | Pubmed ID: 21147463
Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection.
Eukaryotic cell Sep, 2011 | Pubmed ID: 21531875
Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control.
PLoS pathogens Sep, 2011 | Pubmed ID: 21931552
An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.
Infection and immunity Feb, 2012 | Pubmed ID: 22104110
Biochemical and molecular characterization of the pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase from Toxoplasma gondii.
Molecular and biochemical parasitology Aug, 2012 | Pubmed ID: 22580100
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.
Journal of immunology (Baltimore, Md. : 1950) Jan, 2013 | Pubmed ID: 23225891
Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment.
Cancer research Jul, 2013 | Pubmed ID: 23704211
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved